Ida K Haugen Selected Research

4-hexyloxyaniline (HOA)

10/2021	Metabolic Syndrome and Osteoarthritis Distribution in the Hand Joints: A Propensity Score Matching Analysis From the Osteoarthritis Initiative.
1/2019	Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1α and anti-interleukin-1β dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis.
1/2019	Characteristics of Accelerated Hand Osteoarthritis: Data from the Osteoarthritis Initiative.
12/2016	Increased prevalence and severity of radiographic hand osteoarthritis in patients with HIV-1 infection associated with metabolic syndrome: data from the cross-sectional METAFIB-OA study.
9/2011	Prevalence, incidence and progression of hand osteoarthritis in the general population: the Framingham Osteoarthritis Study.
6/2011	Hand osteoarthritis and MRI: development and first validation step of the proposed Oslo Hand Osteoarthritis MRI score.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ida K Haugen Research Topics

Disease

10	Osteoarthritis 01/2022 - 06/2011
10	Pain (Aches) 01/2022 - 01/2011
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2021 - 12/2016
2	Inflammation (Inflammations) 01/2022 - 01/2011
1	Obesity 01/2022
1	Overweight 01/2022
1	Weight Loss (Weight Reduction) 01/2021
1	Osteophyte 11/2020
1	Disease Progression 01/2020
1	Knee Osteoarthritis 01/2020
1	Injection Site Reaction 01/2019
1	Diabetes Mellitus 01/2018
1	Abdominal Obesity 01/2018
1	Hypertension (High Blood Pressure) 01/2018
1	Infections 12/2016
1	HIV Infections (HIV Infection) 12/2016
1	Knee Injuries (Knee Injury) 08/2011
1	Synovitis 01/2011

Drug/Important Bio-Agent (IBA)

6	4-hexyloxyaniline (HOA)IBA 10/2021 - 06/2011
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2020
3	Pharmaceutical PreparationsIBA 01/2022 - 01/2020
1	C-Reactive ProteinIBA 01/2022
1	LeptinIBA 01/2022
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2021
1	Analgesics (Analgesic Drugs)IBA 11/2020
1	AutoantibodiesIBA 01/2020
1	Interleukin-1 (Interleukin 1)IBA 01/2019
1	InterleukinsIBA 01/2019
1	lutikizumabIBA 01/2019
1	KL 3IBA 03/2018
1	HDL LipoproteinsIBA 01/2018
1	Protease Inhibitors (Protease Inhibitor)IBA 12/2016
1	ORALIT (ORS)IBA 08/2011

Therapy/Procedure

2	Pain Management 01/2022 - 01/2011
1	Therapeutics 12/2021
1	Intra-Articular Injections 01/2021
1	Drug Therapy (Chemotherapy) 01/2020
1	Occupational Therapy (Therapy, Occupational) 01/2019
1	Orthotic Devices (Orthosis) 01/2019
1	Self-Help Devices (Assistive Technology) 01/2019